BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gerlich WH. Medical virology of hepatitis B: how it began and where we are now. Virol J. 2013;10:239. [PMID: 23870415 DOI: 10.1186/1743-422x-10-239] [Cited by in Crossref: 152] [Cited by in F6Publishing: 74] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Kim YJ, Li P, Hong JM, Ryu KH, Nam E, Chang MS. A Single Center Analysis of the Positivity of Hepatitis B Antibody after Neonatal Vaccination Program in Korea. J Korean Med Sci 2017;32:810-6. [PMID: 28378555 DOI: 10.3346/jkms.2017.32.5.810] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Faleye TO, Adewumi MO, Ifeorah IM, Omoruyi EC, Bakarey SA, Akere A, Awokunle F, Ajibola HO, Makanjuola DO, Adeniji JA. Detection of hepatitis B virus isolates with mutations associated with immune escape mutants among pregnant women in Ibadan, southwestern Nigeria. Springerplus. 2015;4:43. [PMID: 25674500 DOI: 10.1186/s40064-015-0813-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
3 Xu T, Zhu A, Sun M, Lv J, Qian Z, Wang X, Wang T, Wang H. Quantitative assessment of HLA-DQ gene polymorphisms with the development of hepatitis B virus infection, clearance, liver cirrhosis, and hepatocellular carcinoma. Oncotarget 2018;9:96-109. [PMID: 29416599 DOI: 10.18632/oncotarget.22941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
4 Roman S, Jose-Abrego A, Fierro NA, Escobedo-Melendez G, Ojeda-Granados C, Martinez-Lopez E, Panduro A. Hepatitis B virus infection in Latin America: A genomic medicine approach. World J Gastroenterol 2014; 20(23): 7181-7196 [PMID: 24966588 DOI: 10.3748/wjg.v20.i23.7181] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
5 Ivanov AV, Valuev-Elliston VT, Tyurina DA, Ivanova ON, Kochetkov SN, Bartosch B, Isaguliants MG. Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis. Oncotarget. 2017;8:3895-3932. [PMID: 27965466 DOI: 10.18632/oncotarget.13904] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 22.3] [Reference Citation Analysis]
6 Cruz HM, Scalioni Lde P, de Paula VS, da Silva EF, do Ó KM, Milagres FA, Cruz MS, Bastos FI, Pollo-Flores P, Leal E, Motta-Castro AR, Pilotto JH, Lewis-Ximenez LL, Lampe E, Villar LM. Evaluating HBsAg rapid test performance for different biological samples from low and high infection rate settings & populations. BMC Infect Dis 2015;15:548. [PMID: 26619906 DOI: 10.1186/s12879-015-1249-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
7 Ho JK, Jeevan-Raj B, Netter HJ. Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms. Viruses 2020;12:E126. [PMID: 31973017 DOI: 10.3390/v12020126] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 19.0] [Reference Citation Analysis]
8 Olusola BA, Gometi EA, Ogunsemowo O, Olaleye DO, Odaibo GN. High rate of Hepatitis B virus infection among hairdressers in Ibadan, Nigeria. J Immunoassay Immunochem 2017;38:322-32. [PMID: 28318369 DOI: 10.1080/15321819.2016.1260585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Komatsu H, Inui A, Murano T, Tsunoda T, Sogo T, Fujisawa T. Lack of infectivity of HBV in feces from patients with chronic hepatitis B virus infection, and infection using chimeric mice. BMC Res Notes 2015;8:366. [PMID: 26289533 DOI: 10.1186/s13104-015-1337-z] [Reference Citation Analysis]
10 Karimova M, Beschorner N, Dammermann W, Chemnitz J, Indenbirken D, Bockmann JH, Grundhoff A, Lüth S, Buchholz F, Schulze zur Wiesch J. CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X. Sci Rep. 2015;5:13734. [PMID: 26334116 DOI: 10.1038/srep13734] [Cited by in Crossref: 68] [Cited by in F6Publishing: 66] [Article Influence: 11.3] [Reference Citation Analysis]
11 Gerlich W, Doerr HW. Therapeutic vaccination in chronic hepatitis B--approaches, problems, and new perspectives. Preface. Med Microbiol Immunol 2015;204:1-4. [PMID: 25550114 DOI: 10.1007/s00430-014-0368-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Tummillo KM, Hazlett KRO. Co-Opting Host Receptors for Targeted Delivery of Bioconjugates-From Drugs to Bugs. Molecules 2021;26:1479. [PMID: 33803208 DOI: 10.3390/molecules26051479] [Reference Citation Analysis]
13 Thomas E, Yoneda M, Schiff ER. Viral hepatitis: past and future of HBV and HDV. Cold Spring Harb Perspect Med. 2015;5:a021345. [PMID: 25646383 DOI: 10.1101/cshperspect.a021345] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
14 Kassa Y, Million Y, Gedefie A, Moges F. Alteration of Gut Microbiota and Its Impact on Immune Response in Patients with Chronic HBV Infection: A Review. Infect Drug Resist 2021;14:2571-8. [PMID: 34262302 DOI: 10.2147/IDR.S305901] [Reference Citation Analysis]
15 Calina D, Hartung T, Docea AO, Spandidos DA, Egorov AM, Shtilman MI, Carvalho F, Tsatsakis A. COVID-19 vaccines: ethical framework concerning human challenge studies. Daru 2020;28:807-12. [PMID: 32851596 DOI: 10.1007/s40199-020-00371-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 15.0] [Reference Citation Analysis]
16 Inoue T, Tanaka Y. Hepatitis B virus and its sexually transmitted infection - an update. Microb Cell 2016;3:420-37. [PMID: 28357379 DOI: 10.15698/mic2016.09.527] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
17 He X, Xu H, Wang X, Wu J, Niu J, Gao P. Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population. Mol Med Rep 2019;20:2177-88. [PMID: 31322199 DOI: 10.3892/mmr.2019.10455] [Reference Citation Analysis]
18 Inoue T, Tanaka Y. The Role of Hepatitis B Core-Related Antigen. Genes (Basel) 2019;10:E357. [PMID: 31075974 DOI: 10.3390/genes10050357] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
19 Klasse PJ. Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives. Adv Biol 2014;2014:157895. [PMID: 27099867 DOI: 10.1155/2014/157895] [Cited by in Crossref: 105] [Cited by in F6Publishing: 100] [Article Influence: 15.0] [Reference Citation Analysis]
20 Bazinet M, Anderson M, Pântea V, Placinta G, Moscalu I, Cebotarescu V, Cojuhari L, Jimbei P, Iarovoi L, Smesnoi V, Musteata T, Jucov A, Dittmer U, Gersch J, Holzmayer V, Kuhns M, Cloherty G, Vaillant A. Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy. Hepatol Commun 2021;5:1873-87. [PMID: 34558823 DOI: 10.1002/hep4.1767] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Gerlich WH. Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives. Med Microbiol Immunol. 2015;204:39-55. [PMID: 25523195 DOI: 10.1007/s00430-014-0373-y] [Cited by in Crossref: 63] [Cited by in F6Publishing: 58] [Article Influence: 9.0] [Reference Citation Analysis]
22 Zhang Z, Zhang L, Dai Y, Zhang Y, Li J, Li X. Occult hepatitis B virus infection: influence of S protein variants. Virol J 2016;13:10. [PMID: 26786229 DOI: 10.1186/s12985-016-0464-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
23 Rathi A, Kumar V, Majhi J, Jain S, Lal P, Singh S. Assessment of knowledge, attitude, and practices toward prevention of hepatitis B infection among medical students in a high-risk setting of a newly established medical institution. J Lab Physicians 2018;10:374-9. [PMID: 30498306 DOI: 10.4103/JLP.JLP_93_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
24 Shen T, Yan XM. Hepatitis B virus genetic mutations and evolution in liver diseases. World J Gastroenterol 2014; 20(18): 5435-5441 [PMID: 24833874 DOI: 10.3748/wjg.v20.i18.5435] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
25 Shouval D, Roggendorf H, Roggendorf M. Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S vaccine. Med Microbiol Immunol 2015;204:57-68. [PMID: 25557605 DOI: 10.1007/s00430-014-0374-x] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 12.2] [Reference Citation Analysis]
26 Di Minno G, Perno CF, Tiede A, Navarro D, Canaro M, Güertler L, Ironside JW. Current concepts in the prevention of pathogen transmission via blood/plasma-derived products for bleeding disorders. Blood Rev 2016;30:35-48. [PMID: 26381318 DOI: 10.1016/j.blre.2015.07.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
27 Maldonado-Rodriguez A, Cevallos AM, Rojas-Montes O, Enriquez-Navarro K, Alvarez-Muñoz MT, Lira R. Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance. World J Hepatol 2015; 7(2): 253-260 [PMID: 25729480 DOI: 10.4254/wjh.v7.i2.253] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
28 Alshammari TM, Aljofan M, Subaie G, Hussain T. Knowledge, awareness, attitude, and practice of health-care professionals toward hepatitis B disease and vaccination in Saudi Arabia. Hum Vaccin Immunother 2019;15:2816-23. [PMID: 31226008 DOI: 10.1080/21645515.2019.1629255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Ni L, Li C, Li Y. Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer. Oncol Lett 2020;19:2562-7. [PMID: 32194760 DOI: 10.3892/ol.2020.11257] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Dong J, Ying J, Qiu X, Lu Y, Zhang M. Advanced Strategies for Eliminating the cccDNA of HBV. Dig Dis Sci 2018;63:7-15. [PMID: 29159681 DOI: 10.1007/s10620-017-4842-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
31 Venkatakrishnan B, Zlotnick A. The Structural Biology of Hepatitis B Virus: Form and Function. Annu Rev Virol. 2016;3:429-451. [PMID: 27482896 DOI: 10.1146/annurev-virology-110615-042238] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 14.2] [Reference Citation Analysis]
32 Ganesan M, Eikenberry A, Poluektova LY, Kharbanda KK, Osna NA. Role of alcohol in pathogenesis of hepatitis B virus infection. World J Gastroenterol 2020; 26(9): 883-903 [PMID: 32206001 DOI: 10.3748/wjg.v26.i9.883] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
33 Alarcon V, Hernández S, Rubio L, Alvarez F, Flores Y, Varas-Godoy M, De Ferrari GV, Kann M, Villanueva RA, Loyola A. The enzymes LSD1 and Set1A cooperate with the viral protein HBx to establish an active hepatitis B viral chromatin state. Sci Rep 2016;6:25901. [PMID: 27174370 DOI: 10.1038/srep25901] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
34 He XT, Xu HQ, Wang XM, He XS, Niu JQ, Gao PJ. Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2017; 23(2): 232-241 [PMID: 28127197 DOI: 10.3748/wjg.v23.i2.232] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
35 He X, Li J, Wu J, Zhang M, Gao P. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review). Mol Med Rep 2015;12:6405-14. [PMID: 26398702 DOI: 10.3892/mmr.2015.4312] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
36 Bowen A, Casadevall A. Increasing disparities between resource inputs and outcomes, as measured by certain health deliverables, in biomedical research. Proc Natl Acad Sci U S A 2015;112:11335-40. [PMID: 26283360 DOI: 10.1073/pnas.1504955112] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 7.3] [Reference Citation Analysis]
37 Watanabe T, Inoue T, Tanaka Y. Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B. Microorganisms 2021;9:2083. [PMID: 34683404 DOI: 10.3390/microorganisms9102083] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
38 Petrovskis I, Lieknina I, Dislers A, Jansons J, Bogans J, Akopjana I, Zakova J, Sominskaya I. Production of the HBc Protein from Different HBV Genotypes in E. coli. Use of Reassociated HBc VLPs for Packaging of ss- and dsRNA. Microorganisms 2021;9:283. [PMID: 33573151 DOI: 10.3390/microorganisms9020283] [Reference Citation Analysis]
39 Shaha M, Chakraborty S, Hossain MS, Hashem A, Salimullah M. Molecular evolution and genomics of hepatitis B virus subgenotype C2 strain predominant in the chronic patients in Bangladesh. Virusdisease 2018;29:486-90. [PMID: 30539051 DOI: 10.1007/s13337-018-0497-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
40 Goto K, Kato N. MICA SNPs and the NKG2D system in virus-induced HCC. J Gastroenterol. 2015;50:261-272. [PMID: 25270965 DOI: 10.1007/s00535-014-1000-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
41 Zheng M, Tian Z. Liver-Mediated Adaptive Immune Tolerance. Front Immunol 2019;10:2525. [PMID: 31787967 DOI: 10.3389/fimmu.2019.02525] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 19.5] [Reference Citation Analysis]
42 Chiu AP, Tschida BR, Lo LH, Moriarity BS, Rowlands DK, Largaespada DA, Keng VW. Transposon mouse models to elucidate the genetic mechanisms of hepatitis B viral induced hepatocellular carcinoma. World J Gastroenterol 2015; 21(42): 12157-12170 [PMID: 26576100 DOI: 10.3748/wjg.v21.i42.12157] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
43 Churin Y, Roderfeld M, Roeb E. Hepatitis B virus large surface protein: function and fame. Hepatobiliary Surg Nutr 2015;4:1-10. [PMID: 25713800 DOI: 10.3978/j.issn.2304-3881.2014.12.08] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
44 Thomas E, Liang TJ. Experimental models of hepatitis B and C - new insights and progress. Nat Rev Gastroenterol Hepatol. 2016;13:362-374. [PMID: 27075261 DOI: 10.1038/nrgastro.2016.37] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
45 Gerlich WH, Glebe D, Kramvis A, Magnius LO. Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: a potential source of misunderstandings. Virus Genes 2020;56:109-19. [PMID: 32026198 DOI: 10.1007/s11262-020-01733-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
46 Gu S, Liu Z, Lin L, Zhong S, Ma Y, Li X, Ye G, Wen C, Li Y, Tang L. Identification and Mapping of HBsAg Loss-Related B-Cell Linear Epitopes in Chronic HBV Patients by Peptide Array. Front Immunol 2021;12:767000. [PMID: 34721439 DOI: 10.3389/fimmu.2021.767000] [Reference Citation Analysis]
47 Cruz HM, Scalioni LP, Paula VS, Miguel JC, Ó KM, Milagres FA, Cruz MS, Bastos FI, Flores PP, Leal E, Motta-Castro AR, Lewis-Ximenez LL, Lampe E, Villar LM. Poor sensitivity of rapid tests for the detection of antibodies to the hepatitis B virus: implications for field studies. Mem Inst Oswaldo Cruz 2017;112:209-13. [PMID: 28146158 DOI: 10.1590/0074-02760160394] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
48 Ghosh M, Nandi S, Dutta S, Saha MK. Detection of hepatitis B virus infection: A systematic review. World J Hepatol 2015; 7(23): 2482-2491 [PMID: 26483870 DOI: 10.4254/wjh.v7.i23.2482] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
49 Wu CC, Chen YS, Cao L, Chen XW, Lu MJ. Hepatitis B virus infection: Defective surface antigen expression and pathogenesis. World J Gastroenterol 2018; 24(31): 3488-3499 [PMID: 30131655 DOI: 10.3748/wjg.v24.i31.3488] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
50 Khadka S, Pandit R, Dhital S, Baniya JB, Tiwari S, Shrestha B, Pandit S, Sato F, Fujita M, Sharma M, Tsunoda I, Mishra SK. Evaluation of Five International HBV Treatment Guidelines: Recommendation for Resource-Limited Developing Countries Based on the National Study in Nepal. Pathophysiology 2020;27:3-13. [PMID: 34321716 DOI: 10.3390/pathophysiology27010002] [Reference Citation Analysis]
51 Vieira YR, Portilho MM, Oliveira FF, Guterres A, Dos Santos DRL, Villar LM, Mirazo S, Arbiza J, Dimache LAG, Almeida FQ, Brandão ML, Cordeiro JLP, Rocha FL, Azevedo FC, Lemos FG, Campos JBV, Macedo GC, Herrera HM, Péres IAS, Zimmermann NP, Piovezan U, Pellegrin AO, de Paula VS, Pinto MA. Evaluation of HBV-Like Circulation in Wild and Farm Animals from Brazil and Uruguay. Int J Environ Res Public Health 2019;16:E2679. [PMID: 31357451 DOI: 10.3390/ijerph16152679] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
52 Zhong C, Hou Z, Huang J, Xie Q, Zhong Y. Mutations and CpG islands among hepatitis B virus genotypes in Europe. BMC Bioinformatics 2015;16:38. [PMID: 25652331 DOI: 10.1186/s12859-015-0481-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
53 Samardžija M, Drenjančević D, Miletić M, Slavulj B, Jukić I, Zibar L, Mihaljević S, Ferenac Kiš M, Samardžija M. THE IMPACT OF POSITIVE ANTI-HBC MARKER ON PERMANENT DEFERRAL OF VOLUNTARY BLOOD DONORS IN EASTERN CROATIA AND ESTIMATION OF OCCULT HEPATITIS B VIRUS INFECTION RATE. Acta Clin Croat 2020;59:126-34. [PMID: 32724283 DOI: 10.20471/acc.2020.59.01.15] [Reference Citation Analysis]
54 Tulaeva I, Cornelius C, Zieglmayer P, Zieglmayer R, Schmutz R, Lemell P, Weber M, Focke-Tejkl M, Karaulov A, Henning R, Valenta R. Quantification, epitope mapping and genotype cross-reactivity of hepatitis B preS-specific antibodies in subjects vaccinated with different dosage regimens of BM32. EBioMedicine 2020;59:102953. [PMID: 32855110 DOI: 10.1016/j.ebiom.2020.102953] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
55 Troyer Z, Alhusaini N, Tabler CO, Sweet T, de Carvalho KIL, Schlatzer DM, Carias L, King CL, Matreyek K, Tilton JC. Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies. J Extracell Vesicles 2021;10:e12112. [PMID: 34188786 DOI: 10.1002/jev2.12112] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Webale MK, Budambula V, Lihana R, Musumba FO, Nyamache AK, Budambula NL, Ahmed AA, Ouma C, Were T. Hepatitis B virus sero-profiles and genotypes in HIV-1 infected and uninfected injection and Non-injection drug users from coastal Kenya. BMC Infect Dis 2015;15:299. [PMID: 26223795 DOI: 10.1186/s12879-015-1060-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
57 Khanam A, Chua JV, Kottilil S. Immunopathology of Chronic Hepatitis B Infection: Role of Innate and Adaptive Immune Response in Disease Progression. Int J Mol Sci 2021;22:5497. [PMID: 34071064 DOI: 10.3390/ijms22115497] [Reference Citation Analysis]
58 Ayana DA, Mulu A, Mihret A, Seyoum B, Aseffa A, Howe R. Occult Hepatitis B virus infection among HIV negative and positive isolated anti-HBc individuals in eastern Ethiopia. Sci Rep 2020;10:22182. [PMID: 33335238 DOI: 10.1038/s41598-020-79392-x] [Reference Citation Analysis]
59 Baudi I, Inoue T, Tanaka Y. Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi. Int J Mol Sci. 2020;21. [PMID: 32023902 DOI: 10.3390/ijms21030949] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
60 Saraceni C, Birk J. A Review of Hepatitis B Virus and Hepatitis C Virus Immunopathogenesis. J Clin Transl Hepatol 2021;9:409-18. [PMID: 34221927 DOI: 10.14218/JCTH.2020.00095] [Reference Citation Analysis]
61 Cai Y, Yin W. The Multiple Functions of B Cells in Chronic HBV Infection. Front Immunol 2020;11:582292. [PMID: 33381113 DOI: 10.3389/fimmu.2020.582292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
62 Olubamwo OO, Virtanen JK, Pihlajamäki J, Tuomainen TP. Association of fatty liver disease with mortality outcomes in an Eastern Finland male cohort. BMJ Open Gastroenterol 2019;6:e000219. [PMID: 31275580 DOI: 10.1136/bmjgast-2018-000219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Thomas E, Baumert TF. Hepatitis B Virus-Hepatocyte Interactions and Innate Immune Responses: Experimental Models and Molecular Mechanisms. Semin Liver Dis 2019;39:301-14. [PMID: 31266064 DOI: 10.1055/s-0039-1685518] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
64 Chipetah F, Chirambo A, Billiat E, Shawa IT. Hepatitis B virus seroprevalence among Malawian medical students: A cross-sectional study. Malawi Med J 2017;29:29-31. [PMID: 28567193 DOI: 10.4314/mmj.v29i1.6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Bender D, Hildt E. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis. Int J Mol Sci 2019;20:E4659. [PMID: 31546975 DOI: 10.3390/ijms20184659] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
66 Hu LP, Liu DP, Chen QY, Harrison TJ, He X, Wang XY, Li H, Tan C, Yang QL, Li KW, Fang ZL. Occult HBV Infection May Be Transmitted through Close Contact and Manifest as an Overt Infection. PLoS One 2015;10:e0138552. [PMID: 26457811 DOI: 10.1371/journal.pone.0138552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
67 Sandhu P, Haque M, Humphries-Bickley T, Ravi S, Song J. Hepatitis B Virus Immunopathology, Model Systems, and Current Therapies. Front Immunol 2017;8:436. [PMID: 28450868 DOI: 10.3389/fimmu.2017.00436] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
68 Cai CW, Lomonosova E, Moran EA, Cheng X, Patel KB, Bailly F, Cotelle P, Meyers MJ, Tavis JE. Hepatitis B virus replication is blocked by a 2-hydroxyisoquinoline-1,3(2H,4H)-dione (HID) inhibitor of the viral ribonuclease H activity. Antiviral Res. 2014;108:48-55. [PMID: 24858512 DOI: 10.1016/j.antiviral.2014.05.007] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
69 Botelho-Souza LF, Vasconcelos MPA, Dos Santos AO, Salcedo JMV, Vieira DS. Hepatitis delta: virological and clinical aspects. Virol J 2017;14:177. [PMID: 28903779 DOI: 10.1186/s12985-017-0845-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 10.3] [Reference Citation Analysis]
70 Hou L, Zhao J, Gao S, Ji T, Song T, Li Y, Wang J, Geng C, Long M, Chen J, Lin H, Cai X, Cang Y. Restriction of hepatitis B virus replication by c-Abl-induced proteasomal degradation of the viral polymerase. Sci Adv 2019;5:eaau7130. [PMID: 30775435 DOI: 10.1126/sciadv.aau7130] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
71 Cruz HM, de Paula VS, da Silva EF, do Ó KMR, Milagres FAP, Cruz MS, Bastos FI, da Mota JC, Pollo-Flores P, Leal E, Motta-Castro ARC, Lewis-Ximenez LL, Lampe E, Villar LM. Utility of oral fluid samples for hepatitis B antibody detection in real life conditions. BMC Infect Dis 2019;19:632. [PMID: 31315573 DOI: 10.1186/s12879-019-4183-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
72 Huzair F, Sturdy S. Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000. Stud Hist Philos Biol Biomed Sci 2017;64:11-21. [PMID: 28511068 DOI: 10.1016/j.shpsc.2017.05.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 4.8] [Reference Citation Analysis]
73 Datta S, Chatterjee S, Veer V. Recent advances in molecular diagnostics of hepatitis B virus. World J Gastroenterol 2014; 20(40): 14615-14625 [PMID: 25356025 DOI: 10.3748/wjg.v20.i40.14615] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
74 Yu WH, Cosgrove C, Berger CT, Cheney PC, Krykbaeva M, Kim AY, Lewis-Ximenez L, Lauer GM, Alter G. ADCC-Mediated CD56DIM NK Cell Responses Are Associated with Early HBsAg Clearance in Acute HBV Infection. Pathog Immun 2018;3:2-18. [PMID: 29541698 DOI: 10.20411/pai.v3i1.228] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
75 Yıldız Kaya S, Mete B, Kaya A, Balkan II, Saltoglu N, Tabak ÖF. The role of quantitative HBsAg in patients with HBV DNA between 2000-20,000 IU/ml. Wien Klin Wochenschr 2021;133:647-53. [PMID: 33914152 DOI: 10.1007/s00508-021-01854-7] [Reference Citation Analysis]